Open AccessEffects of the Integrin-Linked Kinase Inhibitor QLT0267 on Squamous Cell Carcinoma of the Head and Neck
Author(s) -
Maher N. Younes,
Orhan G. Yigitbasi,
Yasemin D. Yazici,
Samar A. Jasser,
Cora Bucana,
Adel K. ElNaggar,
Gordon B. Mills,
Jeffrey N. Myers
Publication year - 2007
Publication title -
archives of otolaryngology - head and neck surgery
Language(s) - English
Resource type - Journals
eISSN - 1538-361X
pISSN - 0886-4470
DOI - 10.1001/archotol.133.1.15
Subject(s) - integrin linked kinase , cancer research , cell culture , apoptosis , cell growth , kinase , biology , protein kinase b , microbiology and biotechnology , cell , pathology , chemistry , protein kinase a , medicine , cyclin dependent kinase 2 , biochemistry , genetics
To study the expression of integrin-linked kinase (ILK) in human squamous cell carcinoma of the head and neck (SCCHN) tumor specimens and cell lines and the efficacy of the novel small molecule QLT0267.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom